{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:19:39Z","timestamp":1773411579749,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jsat.2012.04.003","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T15:16:35Z","timestamp":1339773395000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Medically assisted recovery from opiate dependence within the context of the UK drug strategy: Methadone and Suboxone (buprenorphine\u2013naloxone) patients compared"],"prefix":"10.1016","volume":"44","author":[{"given":"Neil","family":"McKeganey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucinda","family":"Cockayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2012.04.003_bb0010","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.puhe.2008.01.007","article-title":"\u2018Topping up\u2019 methadone: An analysis of patterns of heroin use among a treatment sample of Scottish drug users","volume":"122","author":"Bloor","year":"2008","journal-title":"Public Health"},{"key":"10.1016\/j.jsat.2012.04.003_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2009.10.004","article-title":"Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings","volume":"21","author":"Bruce","year":"2010","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2012.04.003_bb0020","series-title":"Statistical power analysis for the behavioural sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.jsat.2012.04.003_bb0030","first-page":"159","article-title":"Pretest\u2013posttest designs in rehabilitation research","volume":"20","author":"Dimitrov","year":"2003","journal-title":"WORK: A Journal of Prevention, Assessment, & Rehabilitation"},{"key":"10.1016\/j.jsat.2012.04.003_bb0155","first-page":"7","article-title":"Review: buprenorphine induction & stabilisation in the treatment of opiate dependence","volume":"7","author":"Doran","year":"2005","journal-title":"Heroin Addiction and Related Clinical Problems"},{"key":"10.1016\/j.jsat.2012.04.003_bb0035","article-title":"The 2007 user satisfaction survey of Tier 2 and 3 service users in England","author":"Gordon","year":"2008","journal-title":"National Treatment Agency for Substance Misuse"},{"key":"10.1016\/j.jsat.2012.04.003_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/002204269702700202","article-title":"Predictors of retention in enhanced and standard methadone maintenance treatment for HIV risk reduction","volume":"27","author":"Grella","year":"1997","journal-title":"Journal of Drug Issues"},{"key":"10.1016\/j.jsat.2012.04.003_bb0045","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2012.04.003_bb0050","series-title":"Drug strategy 2010 reducing demand, restricting supply, building recovery: Supporting people to live a drug free life","author":"Home Office","year":"2010"},{"key":"10.1016\/j.jsat.2012.04.003_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","article-title":"A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2012.04.003_bb0160","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1136\/bmj.c3172","article-title":"Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment","volume":"340","author":"Kimber","year":"2010","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jsat.2012.04.003_bb0070","series-title":"Psychosocial functioning and motivation scales manual","author":"Knight","year":"1994"},{"key":"10.1016\/j.jsat.2012.04.003_bb0165","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.0924-2708.2004.00095.x","article-title":"The clinical use of buprenorphine in opiate addiction: evidence and practice","volume":"16","author":"Law","year":"2004","journal-title":"Acta Neuropsychiatrica"},{"key":"10.1016\/j.jsat.2012.04.003_bb0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/bjc\/azh085","article-title":"The effectiveness of methadone maintenance treatment in controlling crime: an Australian aggregate-level analysis","volume":"45","author":"Lind","year":"2005","journal-title":"British Journal of Criminology"},{"key":"10.1016\/j.jsat.2012.04.003_bb0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1023\/A:1005555519831","article-title":"Sex, drugs, and HIV: does methadone maintenance reduce drug use and risky sexual behavior?","volume":"23","author":"Lollis","year":"2000","journal-title":"Journal of Behavioral Medicine"},{"key":"10.1016\/j.jsat.2012.04.003_bb0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/508187","article-title":"Interactions between buprenorphine and antivirals. The nonnucleoside reverse-transcriptase inhibitors efavirnez and delavirdine","volume":"43","author":"McCance-Katz","year":"2006","journal-title":"Clincal Infectious Diseases"},{"key":"10.1016\/j.jsat.2012.04.003_bb0180","unstructured":"National Records of Scotland. (2011). Drug-related deaths in Scotland 2010. General Register Office For Scotland."},{"key":"10.1016\/j.jsat.2012.04.003_bb0085","unstructured":"National Treatment Agency. (2009). Paul Hayes'speech at the Drug and Alcohol Today Conference. Accessed 01\/02\/12 athttp:\/\/www.nta.nhs.uk\/phspeech-dat.aspx."},{"key":"10.1016\/j.jsat.2012.04.003_bb0090","unstructured":"National Treatment Agency. (2010). NTA fulfils promise on expert group on medication and recovery. Accessed 02\/01\/12 athttp:\/\/www.nta.nhs.uk\/news-expertgroup-2010.aspx."},{"key":"10.1016\/j.jsat.2012.04.003_bb0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-133-1-200007040-00008","article-title":"Pharmacological treatment of heroin dependent patients","volume":"133","author":"O'Connor","year":"2000","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2012.04.003_bb0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.drugalcdep.2005.11.008","article-title":"Impaired decision-making in opiate-dependent subjects: Effect of pharmacological therapies","volume":"83","author":"Pirastu","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2012.04.003_bb0185","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3758\/BRM.40.3.879","article-title":"Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models","volume":"40","author":"Preacher","year":"2008","journal-title":"Behavior Research Methods"},{"key":"10.1016\/j.jsat.2012.04.003_bb0105","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1532-5415.1999.tb01603.x","article-title":"Assessment and control for confounding by indication in observational studies","volume":"47","author":"Psaty","year":"1999","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.jsat.2012.04.003_bb0110","unstructured":"Rb Pharmaceuticals Limited. (2010). Suboxone summary of product characteristics. Accessed 13\/03\/12 atwww.medicines.org.uk."},{"key":"10.1016\/j.jsat.2012.04.003_bb0120","first-page":"1","article-title":"Methadone vs. buprenorphine\/naloxone during opioid substitution treatment: A naturalistic comparison of cognitive performance relative to healthy controls","volume":"7","author":"Rapelli","year":"2007","journal-title":"BMC Clinical Pharmacology"},{"key":"10.1016\/j.jsat.2012.04.003_bb0125","series-title":"The road to recovery: A new approach to tackling Scotland's drug problem","author":"Scottish Government","year":"2008"},{"key":"10.1016\/j.jsat.2012.04.003_bb0140","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0277-9536(95)00125-Q","article-title":"The Swedish SF-36\u00ae Health Survey: I. Evaluation of data quality, scaling assumption, reliability and construct validity across general populations in Sweden","volume":"41","author":"Sullivan","year":"1995","journal-title":"Social Science Medical"},{"key":"10.1016\/j.jsat.2012.04.003_bb0145","series-title":"SF-36\u00ae physical and mental health summary scales: A user's manual","author":"Ware","year":"1994"},{"key":"10.1016\/j.jsat.2012.04.003_bb0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36\u00ae): I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547212000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547212000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:38:44Z","timestamp":1760038724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547212000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0740547212000803"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2012.04.003","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medically assisted recovery from opiate dependence within the context of the UK drug strategy: Methadone and Suboxone (buprenorphine\u2013naloxone) patients compared","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2012.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}